Literature DB >> 27722041

Hypoxemia is an independent predictor of bronchiolitis obliterans following respiratory adenoviral infection in children.

Pei-Qiong Wu1, Xing Li2,3, Wen-Hui Jiang1, Gen-Quan Yin1, Ai-Hua Lei2, Qiang Xiao2, Jian-Jun Huang1, Zhi-Wei Xie1, Li Deng1.   

Abstract

Bronchiolitis obliterans (BO) is an uncommon and severe sequela of chronic obstructive lung disease in children that results from an insult to the lower respiratory tract. Few prognostic factors achieved worldwide acknowledgment. In the present study, we retrospectively collected the children with respiratory adenoviral infection and identified the predictive factors of BO. In the period between Jan 2011 and December 2014, the consecutive in-hospital acute respiratory infection children with positive result for adenovirus were enrolled into the present study. High resolution computerized tomography and clinical symptoms were utilized as the diagnostic technique for BO. Multivariate analysis using a Logistic proportional hazards model was used to test for independent predictors of BO. A total of 544 children were included with 14 (2.57 %) patients developed BO. Compared with children without BO, BO children presented higher LDH (523.5 vs. 348 IU/ml, p = 0.033), lower blood lymphocyte count (2.23 × 109/L vs. 3.24 × 109/L, p = 0.025) and higher incidence of hypoxemia (78.6 vs. 20.8 %, p = 0.000). They presented relatively persistent fever (15.5 vs. 7 days, p = 0.000) and needed longer treatment in hospital (19.5 vs. 7 days, p = 0.000). Concerning treatment, they were given more intravenous γ-globulin (85.7 vs. 36.8 %, p = 0.000), glucocorticoids (78.6 vs. 24.3 %, p = 0.000) and mechanical ventilation (35.7 vs. 5.5 %, p = 0.001). Multiple analyses determined that hypoxemia was the only independent predictor for BO. The present study identified hypoxemia as the independent predictive factor of BO in adenoviral infected children, which was a novel and sensitive predictor for BO.

Entities:  

Keywords:  Adenovirus; Bronchiolitis obliterans; Hypoxemia; Respiratory infection

Year:  2016        PMID: 27722041      PMCID: PMC5030207          DOI: 10.1186/s40064-016-3237-7

Source DB:  PubMed          Journal:  Springerplus        ISSN: 2193-1801


Background

Bronchiolitis obliterans (BO) is an uncommon and severe sequela of chronic obstructive lung disease in children that results from certain insult to the lower respiratory tract. It is featured by tachypnoea, increased anteroposterior chest diameter, crackles, wheezing, and hypoxaemia for at least 30 days after the initial insult. Luminal obstruction with inflammation, granulation tissue, fibrosis, obliteration of the small airways and bronchiectasis are the pathological characteristics (Li et al. 2014; Champs et al. 2011; Xie et al. 2014; Bosa et al. 2008; Mosquera et al. 2014). Due to its poor prognosis and shortage of effective remedy, identification of predictive factors for BO became one of hottest topic in this field. However, few prognostic factors achieved worldwide acknowledgment (Murtagh et al. 2009; Colom and Teper 2009; Yalcin et al. 2003; Khalifah et al. 2004). The latent causes might be the heterogenicity of this disease. BO was a heterogeneous syndrome due to multiple causes. The reported causes were indicated as acute rejection (El-Gamel et al. 1999), lymphocytic bronchitis (Husain et al. 1999), cytomegalovirus pneumonitis (Heng et al. 1998), adenoviral infection (Murtagh et al. 2009), single lung transplant (Hadjiliadis et al. 2002), anti-human leukocyte antigen antibody development (Palmer et al. 2002), and et al. (Champs et al. 2011). The predictors for BO in various backgrounds shall be divergent widely due to different latent mechanisms. Thus prognostic analysis of BO shall be based on a single cause. Adenoviral infection was identified as the major cause for BO in children (Champs et al. 2011; Murtagh et al. 2009; Khalifah et al. 2004). Thus, it is imperative to investigate the predictors for BO following respiratory adenoviral infection in children. In our Women and Children’s Medical Center, a 1400 bed tertiary children’s hospital located in Southern China with a service population of around 20 million people, we routinely test adenovirus in nasopharyngeal swabs by RT-PCR assay or using serum IgM for in-hospital children with acute respiratory infection (ARI) since Jan 2011. In the present study, we retrospectively collected the children with respiratory adenoviral infection and identified the predictive factors of BO.

Methods

Patients

In the period between Jan 2011 and December 2014, the consecutive in-hospital ARI children with positive result for adenovirus in nasopharyngeal swabs by RT-PCR assay or serum IgM/IgG were enrolled into the present study. Diagnosis and classification of ARI followed standard WHO algorithm for ARI. Briefly, children with cough, difficult breathing, or both were diagnosed ARI and screened for fast breathing. Children were classified as Table 1 (WHO 1991; Hazir et al. 2011). Patients with one of following conditions were excluded from this study: patients presented congenital heart disease, congenital pulmonary dysplasia, immunodeficiency disease, malignances, severe organ dysfunction, had recently been pyrexial for 7 days before admission (temperature under the axillary is at or over 37.2 °C, had exhibited clinical evidence of active infection in other organs, had received corticosteroids within 1 week before admission for any reason and those with substantial missing data. The study was approved by the ethical committee of the Guangzhou Medical University, as well as the Guangzhou Women and Children’s Medical Center Hospital; written informed consent was obtained from the patients’ parents.
Table 1

World Health Organization classification of acute respiratory illness in children presenting with cough and/or difficult breathing

ClassificationCriteria
No pneumonia (cough and cold)Respiratory rate (breaths/minute)
<50 (infants 2–11 months)
<40 (children 12–59 months)
No lower chest indrawing
Nonsevere pneumoniaRespiratory rate (breaths/minute)
>50 (infants 2–11 months)
<40 (children 12–59 months)
No lower chest indrawing
Severe pneumoniaLower chest indrawing with or without rapid breathing
Very severe diseaseUnable to drink, convulsions, abnormally sleepy or difficult waking, stridor in calm child or clinically severe malnutrition
World Health Organization classification of acute respiratory illness in children presenting with cough and/or difficult breathing

Diagnosis of adenovirus infection

PCRs with DNA targets utilized 10 μl purified nucleic acid from Qiagen Quantitect Probe PCR kit (Qiagen, Crawley, UK). Thermal cycling conditions were as described previously, except for removal of the 50 °C hold for reverse transcription, and the enzyme activation hold at 95 °C was extended to fifteen minutes for the Qiagen Quantitect Probe PCR kit. All assays were performed in a Lightcycler 480 real-time PCR machine (Roche Diagnostics, Burgess Hill, UK). The Primers were forward “GCC ACG GTG GGG TTT CTA AAC TT”, reverse “GCC CCA GTG GTC TTA CAT GCA CAT C” and the sequence of the probe was “TGC ACC AGA CCC GGG CTC AGG TAC TCC GA” (Bezerra et al. 2011). Serum adenovirus IgM/IgG were tested using diagnostic ELISA kit (IMMUNOLAB GmbH, Kassel).

Identification of BO

High resolution computerized tomography (HRCT) was utilized as the diagnostic technique for BO. It was conducted when children presented tachypnoea, increased anteroposterior chest diameter, crackles, wheezing or hypoxaemia for at least 30 days after the initial of acute respiratory infection. The chest HRCT was performed during quiet breathing and evaluated by 2 blinded radiologists. BO was defined on the presence of bronchiectasis and/or a mosaic pattern. Mosaic pattern was defined as segmental orlobular areas of hypoattenuation that are associated with narrowing of the caliber of the pulmonary vessels.

Data collection and follow up

Data as follows were included: gender, age, history of breast-feeding, premature birth, number of siblings, extention of infection (no pneumonia, pneumonia), and blood tests before treatment such as blood neutrophil count, blood lymphocyte count, alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine kinase (CK), CK-MB, lactate dehydrogenase (LDH), and C-reactive protein (CRP), as well as parameters identified after admission including hypoxemia, mycoplasma co-infection, bacterial co-infection, sepsis, usage of γ-globulin intravenously, use of antibiotics, use of glucocorticoids, mechanical ventilation, length of fever and length of hospital stay. We conducted a routine follow-up from admission to 1 month after delivery and recorded the following in detail: symptoms, concomitant medications and adverse reactions. All the children were followed up regularly, either at the clinic or by telephone.

Statistical analysis

The Kolmogorov–Smirnov test was used to evaluate the normality of distribution. Data were reported as median and range when distribution was not normal. Statistical differences in clinical characteristics between the 2 groups were compared using the t test, the Mann–Whitney test, and Fisher’s exact test. Group comparison tests were performed using the Wilcoxon rank-sum test. Multivariate analysis using a Logistic proportional hazards model was used to test for independent significance by backward elimination of insignificant baseline characteristics and explanatory variables. For all tests, a p value < 0.05 was considered statistically significant, and all p values quoted are 2-sided. Statistical analyses were performed using SPSS v. 20.0 (SPSS Inc., Chicago, IL, USA).

Results

Patient characteristics of children with or without BO following respiratory adenoviral infection

A total of 544 children (398 boys and 146 girls) met the eligibility criteria and were available for analysis. Among the 544 children, 456 children were diagnosed through PCR and 56 were by serum IgM with the rest 32 diagnosed by both methods. In the serology only group, seroconversion were confirmed in 47/56 (83.9 %) patients. The children had a median age of 23 months (range 1–144 months). 14 (2.57 %) patients developed BO who were all diagnosed pneumonia at admission. Compared with children without BO, BO children presented higher LDH (523.5 vs. 348 IU/ml, p = 0.033), lower blood lymphocyte count (2.23 × 109/L vs. 3.24 × 109/L, p = 0.025) and higher incidence of hypoxemia (78.6 vs. 20.8 %, p = 0.000). They presented relatively persistent fever (15.5 vs. 7 days, p = 0.000) and needed longer treatment in hospital (19.5 vs. 7 days, p = 0.000). Concerning treatment, they were given more intravenous γ-globulin (85.7 vs. 36.8 %, p = 0.000), glucocorticoids (78.6 vs. 24.3 %, p = 0.000) and mechanical ventilation (35.7 vs. 5.5 %, p = 0.001) (Table 2).
Table 2

Characteristics of children with or without bronchiolitis obliterans after respiratory adenoviral infection

CharacteristicsNon-BO (n = 530)BO (n = 14) p
Gender0.127
 Male385 (72.6 %)13 (92.9 %)
 Female145 (27.4 %)1 (7.1 %)
Age (months)23.5 (1–144)15.5 (6–72)0.339
History of breast-feeding305 (57.5 %)9 (64.3 %)0.818
Premature birth34(6.4 %)1 (7.1 %)0.610
Number of siblings0 (0–3)1 (0–2)0.096
Diagnosis0.014
 No pneumonia150 (28.3 %)0 (0.0 %)
 Pneumonia380 (71.7 %)14 (100.0 %)
 Hypoxemia110 (20.8 %)11 (78.6 %)0.000
CRP14.92 (0.00–264.74)26.25 (0.51–116.20)0.155
Blood neutrophil count (×109/l)5.49 (0.54–32.8)4.46 (2.19–14.44)0.767
Blood lymphocyte count (×109/l)3.24 (0.36–35.29)2.23 (0.83–6.77)0.025
ALT (IU/ml)18 (3–372)16 (7–112)0.405
AST (IU/ml)41 (15–1400)40.5 (29–391)0.495
CK (IU/ml)88.5 (11–5413)91 (17–1038)0.941
CK–MB (IU/ml)25 (1–436)24 (13–169)0.959
LDH (IU/ml)348 (14–10983)523.5 (254–1945)0.033
Mycoplasma co-infection143 (27.0 %)4 (28.6)0.999
Bacterial co-infection46 (8.7 %)0 (0.0 %)0.621
Sepsis9 (1.7 %)0 (0.0 %)0.999
Use of γ-globulin intravenously195 (36.8 %)12 (85.7 %)0.000
Use of antibiotics509 (96.0 %)14 (100.0 %)0.999
Use of glucocorticoids129 (24.3 %)11 (78.6 %)0.000
Mechanical ventilation29 (5.5 %)5 (35.7 %)0.001
Length of fever (days)7 (0–62)15.5 (6–30)0.000
Length of hospital stay (days)7 (2–74)19.5 (8–55)0.000

BO bronchiolitis obliterans, ALT alanine aminotransferase, AST aspartate aminotransferase, CK creatinine kinase, LDH lactate dehydrogenase, CRP C-reactive protein

Characteristics of children with or without bronchiolitis obliterans after respiratory adenoviral infection BO bronchiolitis obliterans, ALT alanine aminotransferase, AST aspartate aminotransferase, CK creatinine kinase, LDH lactate dehydrogenase, CRP C-reactive protein

Predictors of BO following respiratory adenoviral infection in children

Univariate analysis by Logistic regression revealed that length of hospital stay (p = 0.000, HR 1.086, 95 % CI 1.046–1.127), length of fever (p = 0.003, HR 1.062, 95 % CI 1.020–1.106), use of glucocorticoids (p = 0.000, HR 11.398, 95 % CI 3.131–41.486), mechanical ventilation (p = 0.000, HR 9.598, 95 % CI 3.022–30.480), hypoxemia (p = 0.000, HR 14.000, 95 % CI 3.839–51.050) and use of intravenous γ-globulin (p = 0.002, HR 10.308, 95 % CI 2.283–46.535) were indicated as prognostic factors. Then, multiple analysis by Logistic regression using above parameters determined that hypoxemia was the only independent predictor for BO (p = 0.030, HR 5.046, 95 % CI 1.170–21.765) (Table 3). Then, patients with or without hypoxemia were compared concerning the incidence of BO, which indicated that patients with hypoxemia kept significantly higher incidence of BO than those without hypoxemia (Fig. 1).
Table 3

Logistic analysis of predictive parameters

FactorsUnivariate analysisMultivariate analysis
p HR (95 % CI) p HR (95 % CI)
Length of hospital stay0.0001.086 (1.046–1.127)0.0561.044 (0.999–1.090)
Length of fever0.0031.062 (1.020–1.106)0.9971.000 (0.942–1.062)
Use of glucocorticoids0.00011.398 (3.131–41.486)0.0564.036 (0.964–16.907)
Mechanical ventilation0.0009.598 (3.022–30.480)0.6121.438 (0.354–5.849)
Hypoxemia0.00014.000 (3.839–51.050)0.0305.046 (1.170–21.765)
Use of γ-globulin intravenously0.00210.308 (2.283–46.535)0.4741.935 (0.317–11.806)

95 % CI 95 % confidence interval

Fig. 1

Incidence of BO in adenovirus infected children with or without hypoxemia. BO bronchiolitis obliterans

Logistic analysis of predictive parameters 95 % CI 95 % confidence interval Incidence of BO in adenovirus infected children with or without hypoxemia. BO bronchiolitis obliterans

Discussion

BO is a severe chronic sequelain children following respiratory adenoviral infection (Champs et al. 2011; Murtagh et al. 2009). Due to its low incidence, the predictors of BO were still unclear. Respiratory viral infection was confirmed to be a distinct risk for BO (Khalifah et al. 2004). Among the entire suspected virus, adenovirus was confirmed to be the major causes (Murtagh et al. 2009). Previous studies found that mechanical ventilation, >30 days of hospitalization, multifocal pneumonia and hypercapnia were the predictors of BO in children with acute bronchitis (Murtagh et al. 2009; Colom and Teper 2009; Yalcin et al. 2003; Khalifah et al. 2004). Some studies failed to identify the predictors due to limited sample sizes (Yalcin et al. 2003). Above all, few prognostic factors achieved worldwide acknowledgment, which might due to limited sample sizes and the heterogenicity of this disease. In the present study, we found that hypoxemia was the independent predictor of BO in adenovirus infected children, which was a novel finding. It usually preceded the previous reported risk factors such as hypercapnia and mechanical ventilation (Jouett et al. 2015; Wilson and Matthay 2014), which made it more sensitive than other predictors. The causes and mechanism of development of BO was still unclear (Kim et al. 2006; Gedik et al. 2015; Costa et al. 2005; Mallol et al. 2011). In order to achieve reliable results, prognostic analysis of BO shall be based on simple disease background. Since adenoviral infection was identified as the major cause of BO in children (Murtagh et al. 2009), it is optimal to investigate the predictors for BO following respiratory adenoviral infection in children. Due to the low incidence of BO, multiple center based studies shall be the optimal choice for better understanding of this sequela. In the present study, pulmonary function measurements were not conducted due the ages of BO children. Most of them are younger than 5 years, which made the pulmonary function measurements unreliable due to their incompatibility. Meanwhile, pathological diagnosis was not achieved due to the risk of biopsy in symptomatic young children and reluctance of their parents. However, the diagnosis of BO in most of the studies was not based on pathological diagnosis (Li et al. 2014; Gedik et al. 2015; Giubergia et al. 2015). And diagnosis based on CT and clinical features was acceptable to most of the researchers. We did not test co-infection of other virus and specific types of adenovirus, due to the low incidence of BO and sub-analysis needed multi-center based studies with larger sample sizes.

Conclusions

In summary, the present study identified hypoxemia as the independent predictive factor of BO in adenoviral infected children, which was a novel and sensitive predictor.
  23 in total

1.  Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?

Authors:  Denis Hadjiliadis; Robert D Davis; Scott M Palmer
Journal:  Chest       Date:  2002-10       Impact factor: 9.410

2.  Bronchial responsiveness to methacholine and adenosine 5'-monophosphate (AMP) in young children with post-infectious bronchiolitis obliterans.

Authors:  Do Kyun Kim; Young Yoo; Jinho Yu; Sun Hee Choi; Young Yull Koh
Journal:  Acta Paediatr       Date:  2006-01       Impact factor: 2.299

3.  Post-infectious bronchiolitis obliterans and mannose-binding lectin insufficiency in Argentinean children.

Authors:  Verónica Giubergia; Maximiliano Salim; Jesica Fraga; Nicolás Castiglioni; Luisa Sen; Claudio Castaños; Andrea Mangano
Journal:  Respirology       Date:  2015-05-04       Impact factor: 6.424

4.  Levels of Th1 and Th2 cytokines in children with post-infectious bronchiolitis obliterans.

Authors:  Maria L K Costa; Renato T Stein; Moisés E Bauer; Denise C Machado; Marcus H Jones; Carolina Bertotto; Paulo M C Pitrez
Journal:  Ann Trop Paediatr       Date:  2005-12

Review 5.  Post-infectious bronchiolitis obliterans in children.

Authors:  Natália Silva Champs; Laura M L B F Lasmar; Paulo A M Camargos; Christophe Marguet; Gilberto Bueno Fischer; Helena Teresinha Mocelin
Journal:  J Pediatr (Rio J)       Date:  2011-05-05       Impact factor: 2.197

6.  Clinical prediction rule to diagnose post-infectious bronchiolitis obliterans in children.

Authors:  Alejandro J Colom; Alejandro M Teper
Journal:  Pediatr Pulmonol       Date:  2009-11

7.  Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.

Authors:  D Heng; L D Sharples; K McNeil; S Stewart; T Wreghitt; J Wallwork
Journal:  J Heart Lung Transplant       Date:  1998-12       Impact factor: 10.247

8.  Assessment of nutritional status in children and adolescents with post-infectious bronchiolitis obliterans.

Authors:  Vera Lúcia Bosa; Elza Daniel de Mello; Helena Teresinha Mocelin; Franceliane Jobim Benedetti; Gilberto Bueno Fischer
Journal:  J Pediatr (Rio J)       Date:  2008 Jul-Aug       Impact factor: 2.197

9.  Lower respiratory infections by adenovirus in children. Clinical features and risk factors for bronchiolitis obliterans and mortality.

Authors:  Patricia Murtagh; Verónica Giubergia; Diana Viale; Gabriela Bauer; Hebe Gonzalez Pena
Journal:  Pediatr Pulmonol       Date:  2009-05

10.  Interactive effects of hypoxia, hypercapnia and lung volume on sympathetic nerve activity in humans.

Authors:  Noah P Jouett; Donald E Watenpaugh; Mark E Dunlap; Michael L Smith
Journal:  Exp Physiol       Date:  2015-08-11       Impact factor: 2.969

View more
  6 in total

1.  Epidemiology, clinical presentation and respiratory sequelae of adenovirus pneumonia in children in Kuala Lumpur, Malaysia.

Authors:  Limin Li; Yen Yen Woo; Jessie Anne de Bruyne; Anna Marie Nathan; Sze Ying Kee; Yoke Fun Chan; Chun Wei Chiam; Kah Peng Eg; Surendran Thavagnanam; I-Ching Sam
Journal:  PLoS One       Date:  2018-10-15       Impact factor: 3.240

2.  Aetiology and risks factors associated with the fatal outcomes of childhood pneumonia among hospitalised children in the Philippines from 2008 to 2016: a case series study.

Authors:  Bindongo Price Polycarpe Dembele; Taro Kamigaki; Clyde Dapat; Raita Tamaki; Mariko Saito; Mayuko Saito; Michiko Okamoto; Mary Ann U Igoy; Edelwisa Segubre Mercado; Melisa Mondoy; Veronica L Tallo; Socorro P Lupisan; Shinichi Egawa; Hitoshi Oshitani
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

Review 3.  Postinfectious Bronchiolitis Obliterans in Children: Diagnostic Workup and Therapeutic Options: A Workshop Report.

Authors:  Silvija-Pera Jerkic; Folke Brinkmann; Alistair Calder; Alicia Casey; Megan Dishop; Matthias Griese; Geoffrey Kurland; Mandy Niemitz; Sylvia Nyilas; Dirk Schramm; Ralf Schubert; Michael Tamm; Stefan Zielen; Martin Rosewich
Journal:  Can Respir J       Date:  2020-01-30       Impact factor: 2.409

4.  Analysis of Risk Factors of Bronchiolitis Obliterans in Children with Mycoplasma pneumoniae Bronchiolitis.

Authors:  KunLing Huang; Jianhua Liu; Wenshan Lv; Yajuan Chu; Baochi Li; Peng Wu; Jinfeng Shuai
Journal:  Comput Math Methods Med       Date:  2022-03-01       Impact factor: 2.238

5.  Clinical Analysis and Risk Factors of Bronchiolitis Obliterans After Mycoplasma Pneumoniae Pneumonia.

Authors:  Hao-Qi Zheng; Yu-Cong Ma; Yu-Quan Chen; Yan-Yue Xu; Yan-Lin Pang; Li Liu
Journal:  Infect Drug Resist       Date:  2022-07-28       Impact factor: 4.177

6.  Risk Factors for Post-infectious Bronchiolitis Obliterans in Children: A Systematic Review and Meta-Analysis.

Authors:  Die Liu; Jing Liu; Lipeng Zhang; Yuanmei Chen; Qi Zhang
Journal:  Front Pediatr       Date:  2022-06-09       Impact factor: 3.569

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.